Thorvardur R Halfdanarson

41PUBLICATIONS
187CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedClinimetricsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jul 28, 2026
Multi-center Phase 1 study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388).

|Jul 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

|Jun 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart disease.

|Jun 26, 2026
Small Cell and Large Cell Neuroendocrine Carcinoma of the Colon and Rectum: Population-Based Analysis of Incidence, Survival, and Site-Specific Outcomes.

|Apr 23, 2026
Toward Sustainable Hematology/Oncology Fellowship Training Through Career-Aligned Specialization.

|Mar 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal Carcinoma.

Fares Jamal, Oudai Sahwan, Seyi Abidoye

Pageof 7

Frequent Collaborators

8 joint publications

Mohamad Bassam Sonbol

4 joint publications

Heloisa P Soares

4 joint publications

Tanios Bekaii-Saab

4 joint publications

Ayse Tuba Kendi